Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

EPLIN: a fundamental actin regulator in cancer metastasis?

Collins, Ross J., Jiang, Wen Guo ORCID:, Hargest, Rachel ORCID:, Mason, Malcolm David ORCID: and Sanders, Andrew James ORCID: 2015. EPLIN: a fundamental actin regulator in cancer metastasis? Cancer and Metastasis Reviews 34 (4) , pp. 753-764. 10.1007/s10555-015-9595-8

[thumbnail of Collins et al 2015 (2).pdf]
PDF - Published Version
Available under License Creative Commons Attribution.

Download (5MB) | Preview


Treatment of malignant disease is of paramount importance in modern medicine. In 2012, it was estimated that 162,000 people died from cancer in the UK which illustrates a fundamental problem. Traditional treatments for cancer have various drawbacks, and this creates a considerable need for specific, molecular targets to overcome cancer spread. Epithelial protein lost in neoplasm (EPLIN) is an actin-associated molecule which has been implicated in the development and progression of various cancers including breast, prostate, oesophageal and lung where EPLIN expression is frequently lost as the cancer progresses. EPLIN is important in the regulation of actin dynamics and has multiple associations at epithelial cells junctions. Thus, EPLIN loss in cancer may have significant effects on cancer cell migration and invasion, increasing metastatic potential. Overexpression of EPLIN has proved to be an effective tool for manipulating cancerous traits such as reducing cell growth and cell motility and rendering cells less invasive illustrating the therapeutic potential of EPLIN. Here, we review the current state of knowledge of EPLIN, highlighting EPLIN involvement in regulating cytoskeletal dynamics, signalling pathways and implications in cancer and metastasis.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher: Springer
ISSN: 0167-7659
Date of First Compliant Deposit: 30 March 2016
Date of Acceptance: 15 July 2015
Last Modified: 10 May 2023 19:54

Citation Data

Cited 25 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics